149 related articles for article (PubMed ID: 23083505)
1. Direct costs associated with depressive symptoms in late life: a 4.5-year prospective study.
Luppa M; König HH; Heider D; Leicht H; Motzek T; Schomerus G; Riedel-Heller SG
Int Psychogeriatr; 2013 Feb; 25(2):292-302. PubMed ID: 23083505
[TBL] [Abstract][Full Text] [Related]
2. Health service utilization and costs of depressive symptoms in late life - a systematic review.
Luppa M; Sikorski C; Motzek T; Konnopka A; König HH; Riedel-Heller SG
Curr Pharm Des; 2012; 18(36):5936-57. PubMed ID: 22681171
[TBL] [Abstract][Full Text] [Related]
3. Direct costs associated with depression in old age in Germany.
Luppa M; Heinrich S; Matschinger H; Sandholzer H; Angermeyer MC; König HH; Riedel-Heller SG
J Affect Disord; 2008 Jan; 105(1-3):195-204. PubMed ID: 17568683
[TBL] [Abstract][Full Text] [Related]
4. Healthcare costs associated with recognized and unrecognized depression in old age.
Luppa M; Heinrich S; Angermeyer MC; König HH; Riedel-Heller SG
Int Psychogeriatr; 2008 Dec; 20(6):1219-29. PubMed ID: 18752699
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Depressive Symptoms on Healthcare Costs in Late Life: Longitudinal Findings From the AgeMooDe Study.
Bock JO; Hajek A; Weyerer S; Werle J; Wagner M; Maier W; Stark A; Kaduszkiewicz H; Wiese B; Moor L; Stein J; Riedel-Heller SG; König HH
Am J Geriatr Psychiatry; 2017 Feb; 25(2):131-141. PubMed ID: 27931772
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoeconomic issues in the treatment of depression.
Saklad SR
Pharmacotherapy; 1995; 15(6 Pt 2):76S-83S. PubMed ID: 8587854
[TBL] [Abstract][Full Text] [Related]
7. Depression and cost-related medication nonadherence in Medicare beneficiaries.
Bambauer KZ; Safran DG; Ross-Degnan D; Zhang F; Adams AS; Gurwitz J; Pierre-Jacques M; Soumerai SB
Arch Gen Psychiatry; 2007 May; 64(5):602-8. PubMed ID: 17485612
[TBL] [Abstract][Full Text] [Related]
8. Impact of drug cost sharing on service use and adverse clinical outcomes in elderly receiving antidepressants.
Wang PS; Patrick AR; Dormuth C; Maclure M; Avorn J; Canning CF; Schneeweiss S
J Ment Health Policy Econ; 2010 Mar; 13(1):37-44. PubMed ID: 20571181
[TBL] [Abstract][Full Text] [Related]
9. Geriatric depression, antidepressant treatment, and healthcare utilization in a health maintenance organization.
Fischer LR; Wei F; Rolnick SJ; Jackson JM; Rush WA; Garrard JM; Nitz NM; Luepke LJ
J Am Geriatr Soc; 2002 Feb; 50(2):307-12. PubMed ID: 12028213
[TBL] [Abstract][Full Text] [Related]
10. Excess health care costs of late-life depression - Results of the AgeMooDe study.
Bock JO; Brettschneider C; Weyerer S; Werle J; Wagner M; Maier W; Scherer M; Kaduszkiewicz H; Wiese B; Moor L; Stein J; Riedel-Heller SG; König HH
J Affect Disord; 2016 Jul; 199():139-47. PubMed ID: 27104802
[TBL] [Abstract][Full Text] [Related]
11. The effect of severity of depressive disorder on economic burden in a university hospital in Singapore.
Ho RC; Mak KK; Chua AN; Ho CS; Mak A
Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):549-59. PubMed ID: 23977979
[TBL] [Abstract][Full Text] [Related]
12. Effects of a stepped-care intervention programme among older subjects who screened positive for depressive symptoms in general practice: the PROMODE randomised controlled trial.
van der Weele GM; de Waal MW; van den Hout WB; de Craen AJ; Spinhoven P; Stijnen T; Assendelft WJ; van der Mast RC; Gussekloo J
Age Ageing; 2012 Jul; 41(4):482-8. PubMed ID: 22427507
[TBL] [Abstract][Full Text] [Related]
13. Social activity and improvement in depressive symptoms in older people: a prospective community cohort study.
Isaac V; Stewart R; Artero S; Ancelin ML; Ritchie K
Am J Geriatr Psychiatry; 2009 Aug; 17(8):688-96. PubMed ID: 19625786
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of integrated care for elderly depressed patients in the PRISM-E study.
Wiley-Exley E; Domino ME; Maxwell J; Levkoff SE
J Ment Health Policy Econ; 2009 Dec; 12(4):205-13. PubMed ID: 20195008
[TBL] [Abstract][Full Text] [Related]
15. Frequency of hospitalizations prior to and after conversion to a rebate pharmaceutical in depression patients in Germany.
Kostev K; May U; Ott C; Paul M; Schetschok K; Tingelhoff M; Claus C; Waehlert L
Int J Clin Pharmacol Ther; 2013 May; 51(5):416-22. PubMed ID: 23547855
[TBL] [Abstract][Full Text] [Related]
16. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
[TBL] [Abstract][Full Text] [Related]
17. Good news and bad news: depressive symptoms decline and undertreatment increases with age in home care and institutional settings.
Szczerbińska K; Hirdes JP; Zyczkowska J
Am J Geriatr Psychiatry; 2012 Dec; 20(12):1045-56. PubMed ID: 21952123
[TBL] [Abstract][Full Text] [Related]
18. Could health care costs for depression be decreased if the disorder were correctly diagnosed and treated?
Carta MG; Hardoy MC; Kovess V; Dell'Osso L; Carpiniello B
Soc Psychiatry Psychiatr Epidemiol; 2003 Sep; 38(9):490-2. PubMed ID: 14504731
[TBL] [Abstract][Full Text] [Related]
19. Association of baseline anxiety with depression persistence at 6 months in patients with acute cardiac illness.
Celano CM; Mastromauro CA; Lenihan EC; Januzzi JL; Rollman BL; Huffman JC
Psychosom Med; 2012 Jan; 74(1):93-9. PubMed ID: 22210240
[TBL] [Abstract][Full Text] [Related]
20. Resource use and costs associated with patients treated for depression in primary care.
Sobocki P; Ekman M; Agren H; Krakau I; Runeson B; Mårtensson B; Jönsson B
Eur J Health Econ; 2007 Mar; 8(1):67-76. PubMed ID: 17165073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
